2024 Q3 Form 10-Q Financial Statement

#000073271724000053 Filed on July 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $30.21B $29.80B
YoY Change -0.45% -0.4%
Cost Of Revenue $11.63B $11.44B
YoY Change 7168.75% -3.26%
Gross Profit $18.58B $18.36B
YoY Change -38.45% 1.46%
Gross Profit Margin 61.51% 61.6%
Selling, General & Admin $6.958B $7.043B
YoY Change -3.43% 0.54%
% of Gross Profit 37.44% 38.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.087B $5.072B
YoY Change 8.12% 8.49%
% of Gross Profit 27.37% 27.63%
Operating Expenses $12.05B $7.043B
YoY Change 67.18% -39.7%
Operating Profit $6.538B $5.760B
YoY Change 13.08% -10.14%
Interest Expense -$1.403B $1.699B
YoY Change -184.42% -229.4%
% of Operating Profit -21.46% 29.5%
Other Income/Expense, Net $717.0M -$669.0M
YoY Change -189.4% -162.41%
Pretax Income $1.430B $5.091B
YoY Change -71.29% -17.42%
Income Tax $1.285B $1.142B
% Of Pretax Income 89.86% 22.43%
Net Earnings -$226.0M $3.597B
YoY Change -106.47% -18.93%
Net Earnings / Revenue -0.75% 12.07%
Basic Earnings Per Share -$0.03 $0.49
Diluted Earnings Per Share -$0.03 $0.49
COMMON SHARES
Basic Shares Outstanding 7.170B shares 7.170B shares
Diluted Shares Outstanding 7.208B shares 7.198B shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.093B
YoY Change -67.54%
Cash & Equivalents $2.586B $3.093B
Short-Term Investments
Other Short-Term Assets $11.61B
YoY Change 28.24%
Inventory $2.529B $1.816B
Prepaid Expenses
Receivables $9.068B $9.686B
Other Receivables $0.00
Total Short-Term Assets $29.80B $29.87B
YoY Change -16.34% -18.55%
LONG-TERM ASSETS
Property, Plant & Equipment $148.4B
YoY Change -1.34%
Goodwill $63.43B $67.85B
YoY Change -6.52% 0.0%
Intangibles
YoY Change
Long-Term Investments $281.0M $584.0M
YoY Change -84.79% -78.99%
Other Assets $19.07B $18.81B
YoY Change -1.86% -7.78%
Total Long-Term Assets $363.9B $368.2B
YoY Change -1.93% -0.97%
TOTAL ASSETS
Total Short-Term Assets $29.80B $29.87B
Total Long-Term Assets $363.9B $368.2B
Total Assets $393.7B $398.0B
YoY Change -3.19% -2.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.17B
YoY Change 5.59%
Accrued Expenses
YoY Change
Deferred Revenue $4.059B $3.981B
YoY Change 9.61% 3.86%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $5.249B
YoY Change -65.62%
Total Short-Term Liabilities $40.66B $42.43B
YoY Change -21.33% -21.66%
LONG-TERM LIABILITIES
Long-Term Debt $125.4B
YoY Change -2.08%
Other Long-Term Liabilities $23.88B $24.08B
YoY Change -6.67% -4.66%
Total Long-Term Liabilities $23.88B $24.08B
YoY Change -6.67% -4.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.66B $42.43B
Total Long-Term Liabilities $23.88B $24.08B
Total Liabilities $64.54B $66.51B
YoY Change -16.48% -16.25%
SHAREHOLDERS EQUITY
Retained Earnings -$185.0M $2.000M
YoY Change -97.43% -100.02%
Common Stock $117.0B $119.1B
YoY Change -6.05% -5.79%
Preferred Stock
YoY Change
Treasury Stock (at cost) $15.09B $15.27B
YoY Change -6.58% -5.51%
Treasury Stock Shares
Shareholders Equity $105.3B
YoY Change
Total Liabilities & Shareholders Equity $393.7B $398.0B
YoY Change -3.19% -2.55%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$226.0M $3.597B
YoY Change -106.47% -18.93%
Depreciation, Depletion And Amortization $5.087B $5.072B
YoY Change 8.12% 8.49%
Cash From Operating Activities $10.24B $9.093B
YoY Change -0.98% -8.36%
INVESTING ACTIVITIES
Capital Expenditures $5.302B $4.360B
YoY Change 14.1% 2.11%
Acquisitions
YoY Change
Other Investing Activities $152.0M $344.0M
YoY Change 49.02% -129.84%
Cash From Investing Activities -$5.150B -$4.016B
YoY Change 13.31% -25.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.562B -5.478B
YoY Change -28.27% -351.17%
NET CHANGE
Cash From Operating Activities 10.24B 9.093B
Cash From Investing Activities -5.150B -4.016B
Cash From Financing Activities -5.562B -5.478B
Net Change In Cash -477.0M -401.0M
YoY Change -75.7% -106.0%
FREE CASH FLOW
Cash From Operating Activities $10.24B $9.093B
Capital Expenditures $5.302B $4.360B
Free Cash Flow $4.933B $4.733B
YoY Change -13.29% -16.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P18M
CY2024Q2 us-gaap Interest Expense
InterestExpense
1699000000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
1608000000 usd
us-gaap Interest Expense
InterestExpense
3423000000 usd
us-gaap Interest Expense
InterestExpense
3316000000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3546000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4437000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6941000000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3546000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4437000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6941000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7196000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7180000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7194000000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7198000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7180000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7195000000 shares
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-258000000 usd
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
602000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-860000000 usd
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
493000000 usd
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
954000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-461000000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q2 us-gaap Revenues
Revenues
29797000000 usd
CY2024Q2 t Segment Reporting Information Operations And Support Expenses
SegmentReportingInformationOperationsAndSupportExpenses
18965000000 usd
CY2024Q2 t Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
10832000000 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5072000000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5760000000 usd
CY2023Q2 us-gaap Revenues
Revenues
29917000000 usd
CY2023Q2 t Segment Reporting Information Operations And Support Expenses
SegmentReportingInformationOperationsAndSupportExpenses
18836000000 usd
CY2023Q2 t Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
11081000000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4675000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6406000000 usd
us-gaap Revenues
Revenues
59825000000 usd
t Segment Reporting Information Operations And Support Expenses
SegmentReportingInformationOperationsAndSupportExpenses
38099000000 usd
t Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
21726000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10119000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
11607000000 usd
us-gaap Revenues
Revenues
60056000000 usd
t Segment Reporting Information Operations And Support Expenses
SegmentReportingInformationOperationsAndSupportExpenses
38342000000 usd
t Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
21714000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9306000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
12408000000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5760000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6406000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
11607000000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
1699000000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
1608000000 usd
us-gaap Interest Expense
InterestExpense
3423000000 usd
us-gaap Interest Expense
InterestExpense
3316000000 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
348000000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
380000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
643000000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
682000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
987000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1133000000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5091000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6165000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9960000000 usd
CY2024Q2 us-gaap Revenues
Revenues
29797000000 usd
CY2023Q2 us-gaap Revenues
Revenues
29917000000 usd
us-gaap Revenues
Revenues
59825000000 usd
us-gaap Revenues
Revenues
60056000000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6492000000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6518000000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4155000000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3994000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3142000000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
38744000000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.72
CY2024Q2 us-gaap Defined Benefit Plan Benefit Obligation Period Increase Decrease
DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease
-470000000 usd
CY2023Q2 us-gaap Defined Benefit Plan Benefit Obligation Period Increase Decrease
DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease
-745000000 usd
us-gaap Defined Benefit Plan Benefit Obligation Period Increase Decrease
DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease
-941000000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1169000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1228000000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
165000000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
1000000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
164000000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1169000000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
62000000 usd
CY2024Q2 t Debt Securities Available For Sale Maturity Allocated And Single Maturity Date After One Through Three Years Fair Value
DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughThreeYearsFairValue
192000000 usd
CY2024Q2 t Debt Securities Available For Sale Maturity Allocated And Single Maturity Date After Three Through Five Years Fair Value
DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterThreeThroughFiveYearsFairValue
116000000 usd
CY2024Q2 t Debt Securities Available For Sale Maturity Allocated And Single Maturity Date After Five Years Fair Value
DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterFiveYearsFairValue
799000000 usd
CY2024Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
59000000 usd
CY2024Q2 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
680000000 usd
CY2024Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
0 usd
CY2024Q2 us-gaap Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
50000000 usd
CY2023Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
670000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
5000000 usd
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
39756000000 usd
t Cash Proceeds Received Paid During The Period On Finance Receivables Net Of Remittances
CashProceedsReceivedPaidDuringThePeriodOnFinanceReceivablesNetOfRemittances
684000000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3093000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9528000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6722000000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1000000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1000000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2000000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
109000000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
93000000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
109000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3203000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9622000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6833000000 usd
us-gaap Interest Paid
InterestPaid
3644000000 usd
us-gaap Interest Paid
InterestPaid
3604000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
299000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
335000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8118000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8605000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
270000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
515000000 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
199000000 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
537000000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000732717-24-000053-index-headers.html Edgar Link pending
0000732717-24-000053-index.html Edgar Link pending
0000732717-24-000053.txt Edgar Link pending
0000732717-24-000053-xbrl.zip Edgar Link pending
exhibit1012q24.htm Edgar Link pending
exhibit1022q24.htm Edgar Link pending
exhibit1032q24.htm Edgar Link pending
exhibit3112q24.htm Edgar Link pending
exhibit3122q24.htm Edgar Link pending
exhibit322q24.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
t-20240630.htm Edgar Link pending
t-20240630.xsd Edgar Link pending
t-20240630_cal.xml Edgar Link unprocessable
t-20240630_def.xml Edgar Link unprocessable
t-20240630_lab.xml Edgar Link unprocessable
t-20240630_pre.xml Edgar Link unprocessable
t-20240630_htm.xml Edgar Link completed